Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MET: a new promising biomarker in non-small-cell lung carcinoma.
Pérez-Ramírez C, Cañadas-Garre M, Jiménez-Varo E, Faus-Dáder MJ, Calleja-Hernández MÁ. Pérez-Ramírez C, et al. Pharmacogenomics. 2015;16(6):631-47. doi: 10.2217/pgs.15.11. Epub 2015 Apr 20. Pharmacogenomics. 2015. PMID: 25893986 Review.
PTEN and PI3K/AKT in non-small-cell lung cancer.
Pérez-Ramírez C, Cañadas-Garre M, Molina MÁ, Faus-Dáder MJ, Calleja-Hernández MÁ. Pérez-Ramírez C, et al. Pharmacogenomics. 2015 Nov;16(16):1843-62. doi: 10.2217/pgs.15.122. Epub 2015 Nov 10. Pharmacogenomics. 2015. PMID: 26555006 Review.
Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.
Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Molina MÁ, Robles AI, Villar E, Delgado JR, Faus-Dáder MJ, Calleja-Hernández MÁ. Pérez-Ramírez C, et al. Surg Oncol. 2017 Sep;26(3):278-285. doi: 10.1016/j.suronc.2017.05.004. Epub 2017 May 22. Surg Oncol. 2017. PMID: 28807247 Free article.
Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Villar E, Valdivia-Bautista J, Faus-Dáder MJ, Calleja-Hernández MÁ. Pérez-Ramírez C, et al. Pharmacogenomics J. 2019 Apr;19(2):164-177. doi: 10.1038/s41397-018-0014-8. Epub 2018 Apr 17. Pharmacogenomics J. 2019. PMID: 29662106 Free article.
FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis.
Jiménez Morales A, Maldonado-Montoro M, Martínez de la Plata JE, Pérez Ramírez C, Daddaoua A, Alarcón Payer C, Expósito Ruiz M, García Collado C. Jiménez Morales A, et al. Among authors: perez ramirez c. J Clin Pharmacol. 2019 Apr;59(4):517-531. doi: 10.1002/jcph.1341. Epub 2018 Nov 20. J Clin Pharmacol. 2019. PMID: 30457672
52 results